Enorama Pharma AB (publ) (STO:ERMA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.280
0.00 (0.00%)
Apr 28, 2026, 5:09 PM CET
-90.94%
Market Cap 20.88M
Revenue (ttm) 2.74M
Net Income (ttm) -75.14M
Shares Out 74.59M
EPS (ttm) -1.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 57,206
Average Volume 28,443
Open 0.275
Previous Close 0.280
Day's Range 0.241 - 0.280
52-Week Range 0.211 - 3.580
Beta 1.74
RSI 37.36
Earnings Date May 21, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol ERMA
Full Company Profile

Financial Performance

In 2025, Enorama Pharma AB's revenue was 2.74 million, a decrease of -82.63% compared to the previous year's 15.77 million. Losses were -75.14 million, 71.5% more than in 2024.

Financial Statements

News

There is no news available yet.